Nov 5, 2018
Dear patient,Thank you for entrusting your healthcare to CIS, our physicians, and staff. On October 26, the FDA issued a statement regarding a voluntary recall of 22 batches of the generic medication Irbesartan supplied toScieGen Pharmaceuticals Inc. Since not all Irbesartan medications are being recalled, your pharmacy is the first line of contact to confirm if your medication is part of the recall. If your medication is part of the recall, please call your local CIS office and an alternative medication will be recommended. Per the FDA, patients who are on Irbesartan should continue taking their medication, as the risk of harm to a patient’s health may be higher if the treatment is stopped immediately without any alternative treatment.
As always, CIS wishes to provide excellent care to you, our patients. For more information please read the following online article by clicking the button below:
Thank you for your time and attention to this matter.
CIS Physicians and Staff